5,333
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Challenges of Diagnosing Viral Anterior Uveitis

, MD, , MD, PHD, , MD, , MD, PHD, , MD, PHD, , FRANZCO, PHD, , PHD & , MD, PHD show all
Pages 715-725 | Received 08 Jun 2017, Accepted 05 Jul 2017, Published online: 11 Oct 2017

REFERENCES

  • Tsirouki T, Dastiridou A, Symeonidis C, et al. A Focus on the Epidemiology of Uveitis. Ocul Immunol Inflamm. 2016;1–15.
  • Pathanapitoon K, Dodds EM, Cunningham ET Jr., Rothova A. Clinical Spectrum of HLA-B27-associated Ocular Inflammation. Ocul Immunol Inflamm. 2016;1–8.
  • Kongyai N, Sirirungsi W, Pathanapitoon K, et al. Viral causes of unexplained anterior uveitis in Thailand. Eye (Lond). 2012;26:529–534.
  • Acharya NR, Tham VM, Esterberg E, et al. Incidence and prevalence of uveitis: results from the Pacific Ocular Inflammation Study. JAMA Ophthalmol. 2013;131:1405–1412.
  • Birnbaum AD, Tessler HH, Schultz KL, et al. Epidemiologic relationship between Fuchs heterochromic iridocyclitis and the united states rubella vaccination program. Am J Ophthalmol. 2007;144:424–428.
  • Herbort CP, Rao NA, Mochizuki M. members of scientific committee of first international workshop on ocular S. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop on Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm. 2009;17:160–169.
  • Dana MR, MerayoLloves J, Schaumberg DA, Foster CS. Prognosticators for visual outcome in sarcoid uveitis. Ophthalmology. 1996;103:1846–1853.
  • Rochepeau C, Jamilloux Y, Kerever S, et al. Long-term visual and systemic prognoses of 83 cases of biopsy-proven sarcoid uveitis. Br J Ophthalmol. 2016:1–6.
  • Smith JA, Mackensen F, Sen HN, et al. Epidemiology and course of disease in childhood uveitis. Ophthalmology. 2009;116(1544–51):1551 e1.
  • Haasnoot AJ, Van Tent-Hoeve M, Wulffraat NM, et al. Erythrocyte sedimentation rate as baseline predictor for the development of uveitis in children with juvenile idiopathic arthritis. Am J Ophthalmol. 2015;159(372–7):e1.
  • Edelsten C, Lee V, Bentley CR, Kanski JJ, Graham EM. An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood. Br J Ophthalmol. 2002;86:51–56.
  • Kalinina Ayuso V, Ten Cate HA, Van Der Does P, Rothova A, De Boer JH. Male gender and poor visual outcome in uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2010;149:987–993.
  • Ayuso VK, Ten Cate HAT, Van Der Does P, Rothova A, De Boer JH. Male gender as a risk factor for complications in uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2010;149:994–999.
  • Moradi A, Stroh IG, Reddy AK, et al. Risk of hypotony in juvenile idiopathic arthritis-associated uveitis. Am J Ophthalmol. 2016;169:113–124.
  • Haasnoot AJ, Vernie LA, Rothova A, et al. Impact of juvenile idiopathic arthritis associated uveitis in early adulthood. PLoS One. 2016;11:e0164312.
  • Mandeville JT, Levinson RD, Holland GN. The tubulointerstitial nephritis and uveitis syndrome. Surv Ophthalmol. 2001;46:195–208.
  • Kump LI, Cervantes-Castaneda RA, Androudi SN, Foster CS. Analysis of pediatric uveitis cases at a tertiary referral center. Ophthalmology. 2005;112:1287–1292.
  • Hettinga YM, Scheerlinck LM, Lilien MR, Rothova A, De Boer JH. The value of measuring urinary beta2-microglobulin and serum creatinine for detecting tubulointerstitial nephritis and uveitis syndrome in young patients with uveitis. JAMA Ophthalmol. 2015;133:140–145.
  • Goda C, Kotake S, Ichiishi A, Namba K, Kitaichi N, Ohno S. Clinical features in tubulointerstitial nephritis and uveitis (TINU) syndrome. Am J Ophthalmol. 2005;140:637–641.
  • London NJ, Garg SJ, Moorthy RS, Cunningham ET. Drug-induced uveitis. J Ophthalmic Inflamm Infect. 2013;3:43.
  • Shifera AS, Kopplin L, Lin P, Suhler EB. Drug-induced uveitis. Int Ophthalmol Clin. 2015;55:47–65.
  • Cunningham ET Jr., London NJ, Moorthy R, Garg SJ, Zierhut M. Drugs, Inflammation, and the Eye. Ocul Immunol Inflamm. 2016;24:125–127.
  • Beltz J, Zamir E. Brimonidine Induced Anterior Uveitis. Ocul Immunol Inflamm. 2016;24:128–133.
  • Tugal-Tutkun I, Onal S, Garip A, et al. Bilateral Acute Iris Transillumination. Arch Ophthalmol-Chic. 2011;129:1312–1319.
  • Reddy S, Cubillan LD, Hovakimyan A, Cunningham ET Jr. Inflammatory ocular hypertension syndrome (IOHS) in patients with syphilitic uveitis. Br J Ophthalmol. 2007;91:1610–1612.
  • Davis JL. Ocular syphilis. Curr Opin Ophthalmol. 2014;25:513–518.
  • Tabbara KF. Ocular tuberculosis: anterior segment. Int Ophthalmol Clin. 2005;45:57–69.
  • Gupta V, Gupta A, Rao NA. Intraocular tuberculosis–an update. Surv Ophthalmol. 2007;52:561–587.
  • Jap A, Chee SP. Emerging forms of viral uveitis in the developing world. Int Ophthalmol Clin. 2010;50:155–171.
  • Lin P. Infectious Uveitis. Curr Ophthalmol Rep. 2015;3:170–183.
  • Takase H, Kubono R, Terada Y, et al. Comparison of the ocular characteristics of anterior uveitis caused by herpes simplex virus, varicella-zoster virus, and cytomegalovirus. Jpn J Ophthalmol. 2014;58:473–482.
  • Nalcacioglu-Yuksekkaya P, Ozdal PC, Teke MY, Kara C, Ozturk F. Presumed herpetic anterior uveitis: a study with retrospective analysis of 79 cases. Eur J Ophthalmol. 2014;24:14–20.
  • Van Der Lelij A, Ooijman FM, Kijlstra A, Rothova A. Anterior uveitis with sectoral iris atrophy in the absence of keratitis: a distinct clinical entity among herpetic eye diseases. Ophthalmology. 2000;107:1164–1170.
  • Wensing B, Relvas LM, Caspers LE, et al. Comparison of rubella virus- and herpes virus-associated anterior uveitis clinical manifestations and visual prognosis. Ophthalmology. 2011;118:1905–1910.
  • Chee SP, Bacsal K, Jap A, Se-Thoe SY, Cheng CL, Tan BH. Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. Am J Ophthalmol. 2008;145:834–840.
  • Chee SP, Jap A. Presumed fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes. Am J Ophthalmol. 2008;146(883–9):e1.
  • De Groot-Mijnes JDF, De Visser L, Rothova A, Schuller M, Van Loon AM, Weersink AJL. Rubella virus is associated with Fuchs heterochromic iridocyclitis. Am J Ophthalmol. 2006;141:212–214.
  • Quentin CD, Reiber H. Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor. Am J Ophthalmol. 2004;138:46–54.
  • De Visser L, Braakenburg A, Rothova A, De Boer JH. Rubella virus-associated uveitis: clinical manifestations and visual prognosis. Am J Ophthalmol. 2008;146:292–297.
  • Yoshimura K, Mochizuki M, Araki S, et al. Clinical and Immunological Features of Human T-Cell Lymphotropic Virus Type-I Uveitis. Am J Ophthalmol. 1993;116:156–163.
  • Merle H, Cabre P, Olindo S, Merle S, Smadja D. Ocular lesions in 200 patients infected by the human T-cell lymphotropic virus type 1 in Martinique (French West Indies). Am J Ophthalmol. 2002;134:190–195.
  • Pinheiro SR, Martins-Filho OA, Ribas JG, et al. Immunologic markers, uveitis, and keratoconjunctivitis sicca associated with human T-cell lymphotropic virus type 1. Am J Ophthalmol. 2006;142:811–815.
  • Yamaguchi K, Mochizuki M, Watanabe T, et al. Human T lymphotropic virus type 1 uveitis after Graves’ disease. Br J Ophthalmol. 1994;78:163–166.
  • Hsu WM, Chiou SH, Chen SS, et al. The HIV RNA levels of plasma and ocular fluids in AIDS patients with ophthalmic infections. Ophthalmologica. 2004;218:328–332.
  • Pathanapitoon K, Riemens A, Kongyai N, et al. Intraocular and plasma HIV-1 RNA loads and HIV uveitis. Aids. 2011;25:81–86.
  • Kunavisarut P, Sirirungsi W, Pathanapitoon K, Rothova A. Clinical manifestations of human immunodeficiency virus-induced uveitis. Ophthalmology. 2012;119:1455–1459.
  • Rothova A, Schneider M, De Groot-Mijnes JD. Human immunodeficiency virus-induced uveitis: intraocular and plasma human immunodeficiency virus-1 RNA loads. Ophthalmology. 2008;115:2062–2064.
  • Mahendradas P, Shetty R, Malathi J, Madhavan HN. Chikungunya virus iridocyclitis in Fuchs’ heterochromic iridocyclitis. Indian J Ophthalmol. 2010;58:545–547.
  • Lalitha P, Rathinam S, Banushree K, Maheshkumar S, Vijayakumar R, Sathe P. Ocular involvement associated with an epidemic outbreak of chikungunya virus infection. Am J Ophthalmol. 2007;144:552–556.
  • Babu K, Kini R, Philips M, Subbakrishna DK. Clinical profile of isolated viral anterior uveitis in a South Indian patient population. Ocul Immunol Inflamm. 2014;22:356–359.
  • Agrawal R, Oo HH, Balne PK, Ng L, Tong L, Leo YS. Zika Virus and Eye. Ocul Immunol Inflamm. 2017;1–6.
  • Furtado JM, Esposito DL, Klein TM, Teixeira-Pinto T, Da Fonseca BA. Uveitis Associated with Zika Virus Infection. N Engl J Med. 2016;375:394–396.
  • Miranda-Filho Dde B, Martelli CM, Ximenes RA, et al. Initial description of the presumed congenital Zika Syndrome. Am J Public Health. 2016;106:598–600.
  • Hereth-Hebert E, Bah MO, Etard JF, et al. Ocular complications in survivors of the ebola outbreak in Guinea. Am J Ophthalmol. 2017;175:114–121.
  • Varkey JB, Shantha JG, Crozier I, et al. Persistence of Ebola virus in ocular fluid during convalescence. N Engl J Med. 2015;372:2423–2427.
  • Tiffany A, Vetter P, Mattia J, et al. Ebola virus disease complications as experienced by survivors in sierra leone. Clin Infect Dis. 2016;62:1360–1366.
  • Shantha JG, Crozier I, Hayek BR, et al. Ophthalmic manifestations and causes of vision impairment in ebola virus disease survivors in monrovia, liberia. Ophthalmology. 2017;124:170–177.
  • Kibadi K, Mupapa K, Kuvula K, et al. Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, democratic republic of the congo. J Infect Dis. 1999;179(Suppl 1):S13–4.
  • Mattia JG, Vandy MJ, Chang JC, et al. Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study. Lancet Infect Dis. 2016;16:331–338.
  • Chancellor JR, Padmanabhan SP, Greenough TC, et al. Uveitis and systemic inflammatory markers in convalescent phase of Ebola virus disease. Emerg Infect Dis. 2016;22:295–297.
  • Peponis VG, Chatziralli IP, Parikakis EA, Chaira N, Katzakis MC, Mitropoulos PG. Bilateral multifocal chorioretinitis and optic neuritis due to Epstein–Barr virus: a case report. Case Rep Ophthalmol. 2012;3:327–332.
  • Ostler HB, Thygeson P. The ocular manifestations of herpes zoster, varicella, infectious mononucleosis, and cytomegalovirus disease. Surv Ophthalmol. 1976;21:148–159.
  • Sugiyama K, Ito M, Ichimi R, et al. A case of Epstein-Barr virus infection with exophthalmos and ocular muscle swelling. Acta Paediatr Jpn. 1997;39:694–697.
  • Wong KW, D’Amico DJ, Hedges TR 3rd, Soong HK, Schooley RT, Kenyon KR. Ocular involvement associated with chronic Epstein-Barr virus disease. Arch Ophthalmol. 1987;105:788–792.
  • Boonsopon S, Maghsoudlou A, Kombo NE, Foster CS. A therapeutic trial of valganciclovir in patients with uveitis and positive Epstein–Barr virus early antigen D IgG titers. Eur J Ophthalmol. 2016;26:30–35.
  • Usui M, Sakai J. Three cases of EB virus-associated uveitis. Int Ophthalmol. 1990;14:371–376.
  • Kerr JR, Boyd N. Autoantibodies following parvovirus B19 infection. J Infect. 1996;32:41–47.
  • De Groot-Mijnes JD, Dekkers J, De Visser L, Rothova A, Van Loon AM, De Boer JH. Antibody production against B19 virus in ocular fluid of JIA-associated uveitis patients. Ophthalmology. 2015;122(1270–1272):e1.
  • Corridan PG, Laws DE, Morrell AJ, Murray PI. Tonic pupils and human parvovirus (B19) infection. J Clin Neuroophthalmol. 1991;11:109–110.
  • Heinz C, Plentz A, Bauer D, Heiligenhaus A, Modrow S. Prevalence of parvovirus B19-specific antibodies and of viral DNA in patients with endogenous uveitis. Graefes Arch Clin Exp Ophthalmol. 2005;243:999–1004.
  • Maini R, Edelsten C. Uveitis associated with parvovirus infection. Br J Ophthalmol. 1999;83:1403–1404.
  • Suzuki J, Goto H, Usui M, Sakai J. Serous retinal detachment in a patient with aplastic anemia associated with parvovirus B19 infection. Graefes Arch Clin Exp Ophthalmol. 2007;245:324–326.
  • Jones NP. Fuchs’ heterochromic uveitis: an update. Surv Ophthalmol. 1993;37:253–272.
  • Mocan MC, Kadayifcilar S, Irkec M. In vivo confocal microscopic evaluation of keratic precipitates and endothelial morphology in Fuchs’ uveitis syndrome. Eye (Lond). 2012;26:119–125.
  • Liu Q, Jia Y, Zhang S, et al. Iris autofluorescence in Fuchs’ heterochromic uveitis. Br J Ophthalmol. 2016;100:1397–1402.
  • Megaw R, Agarwal PK. Posner-Schlossman syndrome. Surv Ophthalmol. 2017;62:277–285.
  • Jap A, Sivakumar M, Chee SP. Is Posner Schlossman syndrome benign? Ophthalmology. 2001;108:913–918.
  • Urban B, Bakunowicz-Lazarczyk A, Michalczuk M. Immune recovery uveitis: pathogenesis, clinical symptoms, and treatment. Mediators Inflamm. 2014;2014:971417.
  • Yeo TH, Yeo TK, Wong EP, Agrawal R, Teoh SC. Immune recovery uveitis in HIV patients with cytomegalovirus retinitis in the era of HAART therapy-a 5-year study from Singapore. J Ophthalmic Inflamm Infect. 2016;6:41.
  • Agarwal A, Kumari N, Trehan A, et al. Outcome of cytomegalovirus retinitis in immunocompromised patients without Human immunodeficiency virus treated with intravitreal ganciclovir injection. Graefes Arch Clin Exp Ophthalmol. 2014;252:1393–1401.
  • De Schryver I, Rozenberg F, Cassoux N, et al. Diagnosis and treatment of cytomegalovirus iridocyclitis without retinal necrosis. Brit J Ophthalmol. 2006;90:852–855.
  • De Groot-Mijnes JD, Rothova A, Van Loon AM, et al. Polymerase chain reaction and Goldmann-Witmer coefficient analysis are complimentary for the diagnosis of infectious uveitis. Am J Ophthalmol. 2006;141:313–318.
  • Westeneng AC, Rothova A, De Boer JH, De Groot-Mijnes JD. Infectious uveitis in immunocompromised patients and the diagnostic value of polymerase chain reaction and Goldmann-Witmer coefficient in aqueous analysis. Am J Ophthalmol. 2007;144:781–785.